SCHEMBL867128

SCHEMBL867128

O=C1NCCNC1=O.[N]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21785045 0.96 CRBN (0.47)
SCHEMBL31059 0.96
SCHEMBL9058472 0.96 CRBN (0.47)
Calcium SCHEMBL29977738 0.92
SCHEMBL32662853 0.92
Water SCHEMBL29871097 0.92 CRBN (0.44)
Ammonia Solution, Strong SCHEMBL8471093 0.92 CRBN (0.44)
Bromide SCHEMBL19411899 0.92
Hydrochloric Acid SCHEMBL5740143 0.92 CRBN (0.44)
SCHEMBL2672858 0.92

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9974782-B2 Phosphodiesterase inhibitors and uses thereof THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2018-05-22 US disclosed
US-20170216275-A1 PHOSPHODIESTERASE INHIBITORS AND USES THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2017-08-03 US disclosed
US-9422242-B2 Phosphodiesterase inhibitors and uses thereof THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2016-08-23 US disclosed
US-20150080394-A1 PHOSPHODIESTERASE INHIBITORS AND USES THEREOF COLUMBIA UNIVERSITY (US) 2015-03-19 US disclosed
EP-2379076-B1 PHOSPHODIESTERASE INHIBITORS AND USES THEREOF UNIV COLUMBIA (US) 2014-11-12 EP disclosed
US-8697875-B2 Phosphodiesterase inhibitors and uses thereof THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2014-04-15 US disclosed
US-20120076732-A1 PHOSPHODIESTERASE INHIBITORS AND USES THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2012-03-29 US disclosed
EP-2379076-A1 PHOSPHODIESTERASE INHIBITORS AND USES THEREOF The Trustees of Columbia University in the City of New York (US) 2011-10-26 EP disclosed
WO-2010074783-A1 PHOSPHODIESTERASE INHIBITORS AND USES THEREOF THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2010-07-01 WO disclosed
US-20060167010-A1 Phenylahistin and the phenylahistin analogs, a new class of anti-tumor compounds BEYONDSPRING PHARMACEUTICALS, INC. 2006-07-27 US disclosed
US-7026322-B2 Phenylahistin and the phenylahistin analogs, a new class of anti-tumor compounds NEREUS PHARMACEUTICALS, INC. (US) 2006-04-11 US disclosed
WO-2005011699-A1 PHENYLAHISTIN AND THE PHENYLAHISTIN ANALOGS, A NEW CLASS OF ANTI-TUMOR COMPOUNDS NEREUS PHARMACEUTICALS, INC. (US) 2005-02-10 WO disclosed
US-20040102454-A1 Phenylahistin and the phenylahistin analogs, a new class of anti-tumor compounds BEYONDSPRING PHARMACEUTICALS, INC. 2004-05-27 US disclosed
US-6713480-B2 ADMINISTERING TO VERTEBRATE AN EFFECTIVE TUMOR-GROWTH-INHIBITING PHENYLAHISTIN COMPOUND OR PRODRUG ESTER FOR THERAPY OF CANCER NEREUS PHARMACEUTICALS INC. 2004-03-30 US disclosed
US-20020143021-A1 Phenylahistin and the phenylahistin analogs, a new class of anti-tumor compounds NEREUS PHARMACEUTICALS, INC. 2002-10-03 US disclosed
US-6358957-B1 CANCER THERAPY NEREUS PHARMACEUTICALS, INC. 2002-03-19 US disclosed
US-5338845-A Analgesics, antiinflammatory agent STERLING WINTHROP INC. (US) 1994-08-16 US disclosed
US-4007190-A ANTITUMOR, MICROBIOCIDE MERCK & CO., INC. (US) 1977-02-08 US disclosed